These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30003535)

  • 41. Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study.
    Korinthenberg R; Schessl J; Kirschner J
    Neuropediatrics; 2007 Feb; 38(1):10-7. PubMed ID: 17607598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.
    van Doorn PA; Ruts L; Jacobs BC
    Lancet Neurol; 2008 Oct; 7(10):939-50. PubMed ID: 18848313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.
    Doets AY; Lingsma HF; Walgaard C; Islam B; Papri N; Davidson A; Yamagishi Y; Kusunoki S; Dimachkie MM; Waheed W; Kolb N; Islam Z; Mohammad QD; Harbo T; Sindrup SH; Chavada G; Willison HJ; Casasnovas C; Bateman K; Miller JAL; van den Berg B; Verboon C; Roodbol J; Leonhard SE; Benedetti L; Kuwabara S; Van den Bergh P; Monges S; Marfia GA; Shahrizaila N; Galassi G; Péréon Y; Bürmann J; Kuitwaard K; Kleyweg RP; Marchesoni C; Sedano Tous MJ; Querol L; Illa I; Wang Y; Nobile-Orazio E; Rinaldi S; Schenone A; Pardo J; Vermeij FH; Lehmann HC; Granit V; Cavaletti G; Gutiérrez-Gutiérrez G; Barroso FA; Visser LH; Katzberg HD; Dardiotis E; Attarian S; van der Kooi AJ; Eftimov F; Wirtz PW; Samijn JPA; Gilhuis HJ; Hadden RDM; Holt JKL; Sheikh KA; Karafiath S; Vytopil M; Antonini G; Feasby TE; Faber CG; Gijsbers CJ; Busby M; Roberts RC; Silvestri NJ; Fazio R; van Dijk GW; Garssen MPJ; Straathof CSM; Gorson KC; Jacobs BC;
    Neurology; 2022 Feb; 98(5):e518-e532. PubMed ID: 34937789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of Guillain-Barré Syndrome in the integrated development region of the Federal District and Surrounding Areas (RIDE), Brazil, between 2017 and 2019.
    Oliveira AFM; Silva AWMD; Manga Aridjae U; Bastos MM; Wachira VK; Gallo LG
    Acta Trop; 2022 May; 229():106366. PubMed ID: 35150642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Establishment of a single-center-based early prognostic scoring system for Guillain-Barré syndrome.
    Di X; Wang J; Li L; Liu L
    BMC Neurol; 2023 Mar; 23(1):97. PubMed ID: 36870949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey.
    Chiò A; Cocito D; Leone M; Giordana MT; Mora G; Mutani R;
    Neurology; 2003 Apr; 60(7):1146-50. PubMed ID: 12682322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sural nerve involvement in Guillain-Barré syndrome: Clinical and prognostic implications. A prospective cohort.
    López-Hernández JC; Rivas-Cruz MA; Galnares-Olalde JA; López-Alderete JA; López-Pizano A; Alcalá RE; Villanueva AV; Vargas-Cañas ES
    J Clin Neurosci; 2023 Apr; 110():48-52. PubMed ID: 36791495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fasting Glucose Levels Correlate with Disease Severity of Guillain-Barré Syndrome.
    Wang Y; Li G; Yang S; Gu X; Li X; Liu M; Wu X; Guan Y; Press R; Zhu J; Zhang HL
    PLoS One; 2015; 10(12):e0145075. PubMed ID: 26684748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyponatraemia in Guillain-Barré syndrome revisited.
    Hiew FL; Winer JB; Rajabally YA
    Acta Neurol Scand; 2016 Apr; 133(4):295-301. PubMed ID: 26184092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.
    Puma A; Benoit J; Sacconi S; Uncini A
    BMC Neurol; 2018 Jul; 18(1):101. PubMed ID: 30031375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guillain Barré syndrome--Incidence and clinical course in Southern Rogaland, Norway.
    Farbu E; Rudolph T; Stefansdottir S
    Clin Neurol Neurosurg; 2016 Feb; 141():33-7. PubMed ID: 26724429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes mellitus exacerbates the clinical and electrophysiological features of Guillain-Barré syndrome.
    Bae JS; Kim YJ; Kim JK
    Eur J Neurol; 2016 Mar; 23(3):439-46. PubMed ID: 26511168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prediction effects of thyroid function in the severity of Guillain-Barré syndrome.
    Kong L; Wu X; Cheng Y; Liu S; Liu K; Li C
    Neurol Sci; 2022 Aug; 43(8):5017-5028. PubMed ID: 35469074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Guillain Barré syndrome in a population less than 15 years old in Brazil.
    Dias-Tosta E; Kückelhaus CS
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):367-73. PubMed ID: 12131933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subtypes and Prognosis of Guillain-Barré Syndrome in Southwest China.
    Zhang G; Li Q; Zhang R; Wei X; Wang J; Qin X
    PLoS One; 2015; 10(7):e0133520. PubMed ID: 26200903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
    Korinthenberg R; Schessl J; Kirschner J; Mönting JS
    Pediatrics; 2005 Jul; 116(1):8-14. PubMed ID: 15995024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Post-Traumatic brain injury (TBI) presenting with Guillain-Barré syndrome and elevated anti-ganglioside antibodies: a case report and review of the literature.
    Carr KR; Shah M; Garvin R; Shakir A; Jackson C
    Int J Neurosci; 2015; 125(7):486-92. PubMed ID: 25158009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
    Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
    Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria.
    Boostani R; Ramezanzadeh F; Saeidi M; Khodabandeh M
    Iran J Neurol; 2019 Apr; 18(2):64-69. PubMed ID: 31565202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.